TGFB1 and neoplasm: Because TGFβ shows highly pleiotropic actions, in addition to the tumor itself, healthy tissues can be affected by the systemic inhibition of TGFβ, which can lead to unwanted side effects and safety concerns.23 Therefore, we need to better understand the underlying molecular mechanisms by which TGFβ signaling controls normal and malignant processes.